[go: up one dir, main page]

Latest News for: ibd

Edit

Some IBD Patients Produce Antibodies That Block Key Inflammation Regulator, Study Finds

Natural News 05 Jul 2026
Study Finds Autoantibodies Against IL-10 in Subset of IBD PatientsApproximately 3.5 percent of people with inflammatory bowel disease (IBD) produce ... .
Edit

Century Health and Arizona Gastrointestinal Associates Partner to Accelerate Real-World Evidence in IBD and MASH

PR Newswire 23 Jun 2026
IBD and MASH are serious and potentially life-threatening conditions where delays in diagnosis and appropriate treatment can lead to severe complications ... IBD has more than 23 approved therapies but no cure.
Edit

cAMPfield Launches With $180 Million Series A to Advance Prifemilast, a Potential Best-in-Class Oral Therapy for IBD

PR Newswire 18 Jun 2026
... (IBD) ... Recent proof-of-concept data support the therapeutic potential of PDE4 inhibition in ulcerative colitis and underscore this mechanism's potential to address persistent unmet needs in IBD.
Edit

cAMPfield Launches With $180 Million Series A to Advance Prifemilast, a Potential Best-in-Class Oral Therapy for IBD (Forbion Capital Partners Management Services BV)

Public Technologies 18 Jun 2026
) Oral PDE4 inhibitors have demonstrated efficacy in Phase 2 studies of ulcerative colitis cAMPfield's lead candidate is prifemilast, a potentially best-in-class PDE4 inhibitor for the treatment of IBD, in-licensed from Newsoara Biopharma Co., Ltd.
Edit

Saturday Citations: JAXA collaboration with toy company TOMY; a new brain-computer interface; IBD solved

Phys Dot Org 13 Jun 2026
IBD encompasses Crohn's disease and ulcerative colitis and commonly begins in adolescence or early adulthood ... The findings could lead to personalized approaches for diagnosing and treating IBD.
Edit

Calibr-Skaggs Advances CLF065, a Regenerative GLP-2 Therapy, into Two Phase 2 IBD Studies

Business Wire 10 Jun 2026
... peptide-2 (GLP-2) receptor agonist in development for inflammatory bowel diseases (IBD).
Edit

Crohn's & Colitis Foundation Launches 2026 "Spill Your Guts" PSA, Spotlighting Real IBD Stories to Break Stigma

PR Newswire 10 Jun 2026
Through these shared experiences, the Foundation aims to raise awareness of IBD, prompt those experiencing symptoms to seek medical guidance, and inspire individuals with a diagnosis to connect with the organization for support.
Edit

Inflammatory bowel disease (IBD) |23 May 2026

Nation 23 May 2026
It is common for people to confuse IBD (Inflammatory bowel disease) and IBS (Irritable Bowel Syndrome) ... IBD on the other hand is more life threatening ... The awareness campaign helps bring greater visibility to the life-altering impacts of IBD.
Edit

Human gut chip reveals three hidden drivers behind IBD damage and cancer risk

Interesting Engineering 21 May 2026
Inflammatory bowel disease (IBD) has long been difficult to treat because scientists still do not fully understand what drives the chronic inflammation, tissue damage, and scarring seen in patients ... The study addresses a major gap in IBD research.
×